期刊文献+

A 32-gene risk index: a new prognostic approach for prostate cancer progression

A 32-gene risk index: a new prognostic approach for prostate cancer progression
下载PDF
导出
摘要 Radical prostatectomy (RP) has been a widely accepted and standard treat-ment for clinically localized and locally advanced prostate cancer. However, effective clinical management of RP patient remains being challenged, given that conventional prognostic factors, including Gleason score, pT stage, surgical margin status and presurgery serum prostatespecific antigen (PSA), Radical prostatectomy (RP) has been a widely accepted and standard treat-ment for clinically localized and locally advanced prostate cancer. However, effective clinical management of RP patient remains being challenged, given that conventional prognostic factors, including Gleason score, pT stage, surgical margin status and presurgery serum prostatespecific antigen (PSA),
出处 《Asian Journal of Andrology》 SCIE CAS CSCD 2013年第5期590-591,共2页 亚洲男性学杂志(英文版)
  • 相关文献

参考文献8

  • 1Siegel R, Naishadham D, Jemel A. Cancer statistics, 2013. CA CancerJ Clin 2013; 63:11-30.
  • 2Han M, Partin AW, Pound CR, Epstein JI, Walsh PC. Long-term biochemical disease-free and cancer- specific survival following anatomic radical retropubic prostatectomy. The 15-year Johns Hopkins experience. Urol Clin North Am 2001; 28: 555-65.
  • 3Partin AW, Oesterling JE. The clinical usefulness of prostate specific antigen: update 1994. J Urol 1994; 152: 1358-68.
  • 4Stephenson A J, Kattan MW, Eastham JA, Dotan ZA, Bianco FJ Jr etal. Defining biochemical recurrence of prostate cancer after radical prostatectomy: a proposal for a standardized definition. J Clin Oncol 2006; 24: 3973-8.
  • 5Miyake H, Hara I, Kurahashi T, Inoue TA, Eto H etal. Quantitative detection of micrometastases in pelvic lymph nodes in patients with clinically localized prostate cancer by real-time reverse transcriptase- PCR. Clin Cancer Res 2007; 13:1192-7.
  • 6Bolla M, van Poppel H, Tombal B, Vekemans K, da Pozzo Let al. Postoperative radiotherapy after radical prostatectomy for high-risk prostate cancer: long-term results of a randomised controlled trial (EORTC trial 22911). Lancet2012; 380: 2018-27.
  • 7Psutka SP, Feldman AS, Rodin D, Olumi AF, Wu CL et al. Men with organ-confined prostate cancer and positive surgical margins develop biochemical failure at a similar rate to men with extracapsular extension. Urology2011; 78: 121-5.
  • 8Wu CL, Schroeder BE, Ma X J, Cutie C J, Wu S et al. Development and validation of a 32-gene prognostic index for prostate cancer progression. Proc Natl Acad Sci USA 2013: 110: 6121-6.

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部